Natural history and real-world treatment outcomes for NSCLC patients with EGFR exon 20 insertion mutation: An IASLC- ASCO CancerLinQ study

2021

Behera M, Jiang R, Huang Z, Bunn B, Wynes M, Switchenko J, Scagliotti G, Belani C, Ramalingam S